glp 1 drugs for sleep apnea FDA approves weight-loss drug Zepbound to treat Latest Insights on GLP-1 Therapy

Metabolism 55 , 12861292 (2006)

Under the collaboration, cardiometabolic company 9amHealth will leverage obesity medications applied orally from Cost Plus Drugs to help treat conditions like diabetes and hypertension, according to a company announcement

The medications now target multiple organ systems, including the pancreas, stomach, brain, heart, kidneys, immune system, skeletal muscle, adipose tissue, and liver, addressing multiple chronic conditions simultaneously rather than just treating obesity

Standard chow (CE-2, CLEA japan) and water were available ad libitum

Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial